Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
This technology is related to optimal conditions for culturing stem cells and feeder cells More
A pharmaceutical composition comprising HS024 as an active ingredient in an amount effective to protect neuronal cell and to treat or prevent human or mammal suffering from brain diseases such as brain stroke and degenerative brain diseases, together More
A strategy for artificially inducing the internalization of surface receptors, thereby blocking the effects of the ligands associated with that receptor More
Different myeloma tumor cell lines and their expansion for use in drug screening and research More
We have developed a methodology for a chemically defined and effcient protocol which targets human embryonic stem cells towards a chondroprogenitor phenotype. More
Bio-mimicking (3D cell culture) research tools for drug development More
Related Reports
Market Research Reports provided by reports.iptechex.com
Feb 2011 - 209 pages - $3,500
Aug 2010 - 80 pages - $1,215
Jan 2011 - 124 pages - $1,740
Apr 2009 - 159 pages - $3,835
Apr 2011 - 24 pages - $500
Jan 2011 - 99 pages - $3,835
Aug 2010 - 138 pages - $1,215
Sep 2010 - 15 pages - $99
Dec 2010 - 27 pages - $500
May 2011 - 32 pages - $500
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us